Maarten Van Roy

1.1k total citations · 1 hit paper
16 papers, 849 citations indexed

About

Maarten Van Roy is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Maarten Van Roy has authored 16 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Maarten Van Roy's work include Monoclonal and Polyclonal Antibodies Research (5 papers), interferon and immune responses (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Maarten Van Roy is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), interferon and immune responses (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Maarten Van Roy collaborates with scholars based in Belgium, United Kingdom and Netherlands. Maarten Van Roy's co-authors include Tinneke Denayer, Thomas Stöhr, Hans Ulrichts, Alex Hemeryck, Judith Baumeister, Michel Vierboom, Cedric Ververken, Els Beirnaert, Bert ’t Hart and Sofie Poelmans and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Maarten Van Roy

16 papers receiving 837 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Animal models in translational medicine: Validation and prediction

2014 324 citations Tinneke Denayer, Thomas Stöhr et al. SHILAP Revista de lepidopterología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maarten Van Roy Belgium	9	344	263	218	176	71	16	849
Annette Schwartz United States	12	297 0.9×	261 1.0×	259 1.2×	199 1.1×	32 0.5×	17	918
Brian Gordon United States	16	302 0.9×	168 0.6×	272 1.2×	135 0.8×	60 0.8×	35	1.2k
Steven Duniho United States	11	437 1.3×	272 1.0×	195 0.9×	515 2.9×	75 1.1×	16	1.2k
Morteza Motallebnezhad Iran	19	390 1.1×	139 0.5×	382 1.8×	230 1.3×	38 0.5×	37	1.1k
Hailong Liu China	22	661 1.9×	251 1.0×	184 0.8×	229 1.3×	79 1.1×	93	1.6k
Péter Gogolák Hungary	23	492 1.4×	192 0.7×	695 3.2×	185 1.1×	32 0.5×	58	1.5k
Gábor Koncz Hungary	17	417 1.2×	102 0.4×	487 2.2×	194 1.1×	30 0.4×	43	1.0k
Brian P. McCarthy United States	17	301 0.9×	72 0.3×	299 1.4×	136 0.8×	68 1.0×	37	1.0k
Anna Longo Italy	21	384 1.1×	124 0.5×	757 3.5×	214 1.2×	38 0.5×	57	1.5k

Countries citing papers authored by Maarten Van Roy

Since Specialization

Citations

This map shows the geographic impact of Maarten Van Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten Van Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten Van Roy more than expected).

Fields of papers citing papers by Maarten Van Roy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten Van Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten Van Roy. The network helps show where Maarten Van Roy may publish in the future.

Co-authorship network of co-authors of Maarten Van Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten Van Roy. A scholar is included among the top collaborators of Maarten Van Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten Van Roy. Maarten Van Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Desmyter, Aline, Silvia Spinelli, Carlo Boutton, et al.. (2017). Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine–Nanobody Complex. Frontiers in Immunology. 8. 884–884. 37 indexed citations

Scheltinga, Anton G.T. Terwisscha van, Christine Knuehl, Maarten Van Roy, et al.. (2017). Human Epidermal Growth Factor Receptor 3–Specific Tumor Uptake and Biodistribution of⁸⁹Zr-MSB0010853 Visualized by Real-Time and Noninvasive PET Imaging. Journal of Nuclear Medicine. 58(8). 1210–1215. 42 indexed citations

Roy, Maarten Van, Cedric Ververken, Els Beirnaert, et al.. (2015). The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis. Arthritis Research & Therapy. 17(1). 135–135. 145 indexed citations

Denayer, Tinneke, Thomas Stöhr, & Maarten Van Roy. (2014). Animal models in translational medicine: Validation and prediction. SHILAP Revista de lepidopterología. 2(1). 5–5. 324 indexed citations breakdown →

Momi, Stefania, Michela Tantucci, Maarten Van Roy, et al.. (2013). Reperfusion of cerebral artery thrombosis by the GPIb–VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs. Blood. 121(25). 5088–5097. 55 indexed citations

Hauwermeiren, Filip Van, Marietta Armaka, Niki Karagianni, et al.. (2013). Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium. Journal of Clinical Investigation. 123(6). 2590–2603. 66 indexed citations

Maussang, David, Francis J. Descamps, Catelijne Stortelers, et al.. (2013). Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo. Journal of Biological Chemistry. 288(41). 29562–29572. 124 indexed citations

Roy, Maarten Van, et al.. (2013). FRI0021 Alx-0061, an anti-IL-6r nanobody® for therapeutic use in rheumatoid arthritis, demonstrates in vitro a differential biological activity profile as compared to tocilizumab. Annals of the Rheumatic Diseases. 72. A375–A375. 4 indexed citations

Al‐Mossawi, Hussein, Maarten Van Roy, Rainer H. Straub, et al.. (2012). AB0098 A unique subset of rheumatoid arthritis defined by a distinct serum cytokine profile. Annals of the Rheumatic Diseases. 71. 643–643. 1 indexed citations

10.

Samadfam, Rana, et al.. (2012). ALX-0141, an anti-rank-L targeting nanobody®, increases bone mass in cynomolgus monkeys. Bone. 50. S46–S46. 3 indexed citations

11.

Roy, Maarten Van, et al.. (2012). Nonclinical safety assessment of the RANK-L targeting Nanobody® ALX-0141. Toxicology Letters. 211. S44–S44. 1 indexed citations

12.

Roy, Maarten Van, Ben Wielockx, Andrew H. Baker, & Claude Libert. (2007). The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferonγ antitumor therapy. Cancer Gene Therapy. 14(4). 372–379. 5 indexed citations

13.

Molle, Wim Van, Maarten Van Roy, Tom Van Bogaert, et al.. (2007). Protection of Zinc against Tumor Necrosis Factor–Induced Lethal Inflammation Depends on Heat Shock Protein 70 and Allows Safe Antitumor Therapy. Cancer Research. 67(15). 7301–7307. 30 indexed citations

14.

Roy, Maarten Van, Philippe Van Lint, Ben Wielockx, et al.. (2007). Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNγ–based cancer therapy in mice. Molecular Cancer Therapeutics. 6(9). 2563–2571. 8 indexed citations

15.

Wielockx, Ben, Jan Staelens, Leen Puimège, et al.. (2007). Description and Mapping of the Resistance of DBA/2 Mice to TNF-Induced Lethal Shock. The Journal of Immunology. 178(8). 5069–5075. 1 indexed citations

16.

Vaughan, Keith, et al.. (1987). Triazene metabolism. VI. 3-Azidomethyl-3-alkyl-1-aryltriazenes, a new class of anti-tumour triazene with potential pro-drug applications.. PubMed. 2(3). 279–87. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact